BioConnect Inc.

BioConnect Inc. is a Toronto-based technology company specializing in multi-modal biometric authentication solutions, focusing on facial recognition and fingerprint reading to enhance security across various sectors. Founded in 2010 and headquartered in Toronto, Canada, BioConnect Inc. develops advanced biometric authentication solutions.

The company has undergone strategic pivots to enhance its offerings and has secured CAD 2 million in VENTURE DEBT financing from BDC Capital on July 23, 2020. BioConnect has completed two significant deals since its inception. BioConnect specializes in multi-modal authentication solutions that leverage advanced biometric technologies, primarily focusing on facial recognition and fingerprint reading capabilities. Their core product offerings include an AI-driven authentication platform that integrates seamlessly with existing physical access control systems, enabling secure access to data centers, financial services, healthcare facilities, educational institutions, and other regulated markets.

The platform's advanced features, such as automatic enrollment through a 'No Enrollment' function, allow organizations to utilize existing profile images for quick biometric verification without requiring users to re-enroll. BioConnect's clients include enterprises from various sectors, including utilities, telecoms, and stadium operators, and the company serves a global market, with products deployed across North America, Europe, and Asia, addressing the growing demand for compliance with stringent data protection regulations. In the most recent year, 2018, BioConnect reported revenue of CAD 11,400,000. The company generates revenue through a subscription-based model and direct sales of its biometric authentication devices and software solutions, which are tailored for enterprise-level deployments.

The company's flagship products, including the Arc Vision, Arc Touch, and Arc Rex, are marketed to businesses seeking robust security solutions for access control. Transactions commonly occur as B2B engagements, where clients typically purchase licenses for the software alongside the necessary hardware to implement multi-modal authentication systems within their facilities. Revenue streams are supported by ongoing managed services and updates that enhance system capabilities, ensuring that clients maintain compliance with evolving privacy standards. The company positions its offerings as essential tools for organizations looking to mitigate risks associated with unauthorized access and to comply with regulations such as GDPR, BIPA, and CCPA.

BioConnect plans to leverage its recent CAD 2 million VENTURE DEBT financing raised in July 2020 to innovate and expand its product line, focusing on the development of new biometric solutions scheduled for release in the upcoming year. The company is targeting expansion into new geographic regions, specifically aiming to increase its presence in Asia and Europe by 2022, capitalizing on the growing demand for biometric security solutions in these markets.